Duquesne Family Office’s Medicines Co MDCO Stock Holding History

Duquesne Family Office’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-585,500	Closed	-$49.7M	–	71
2019 Q4	$49.7M	Hold	585,500	–	–	1.46%	22
2019 Q3	$29.3M	Buy	+585,500	New	+$23.4M	1.14%	22

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Duquesne Family Office's MDCO Position: Q1 2020 in Review

Duquesne Family Office sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 585,500 shares — an estimated $49.7M sold.

Duquesne Family Office first reported a position in MDCO in Q3 2019 and held it in 2 quarters. The position peaked at $49.7M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Duquesne Family Office reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Duquesne Family Office sold 585,500 Medicines Co shares in Q1 2020, an estimated $49.7M.
Duquesne Family Office first reported a position in Medicines Co in Q3 2019 and held it in 2 quarters.
Duquesne Family Office's Medicines Co position peaked at $49.7M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Duquesne Family Office's 13F filing for Q1 2020, filed 15 May 2020.